Pharvaris (PHVS) Cash & Current Investments (2019 - 2026)

Pharvaris posted quarterly Cash & Current Investments of $341.5 million for Q1 2026, up 15.64% year-on-year from $295.3 million in Q1 2025, and up 0.58% on a QoQ basis from $339.5 million in Q4 2025.

Pharvaris (PHVS) has 8 years of Cash & Current Investments data on file, last reported at $341.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Cash & Current Investments rose 15.64% year-over-year to $341.5 million; the trailing twelve-month figure through Mar 2026 stood at $341.5 million (up 15.64% YoY), and the FY2025 full-year result was $329.5 million, up 8.46% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $341.5 million, up from $339.5 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $420.9 million in Q4 2023 and bottomed at $165.1 million in Q4 2022.
  • The 5-year median for Cash & Current Investments is $319.8 million (2024), against an average of $310.4 million.
  • The widest annual swing landed in 2022, when Cash & Current Investments sank 31.06%; it then surged 154.94% in 2023.
  • A 5-year view of Cash & Current Investments shows it stood at $165.1 million in 2022, then soared by 154.94% to $420.9 million in 2023, then fell by 28.73% to $300.0 million in 2024, then gained by 13.18% to $339.5 million in 2025, then advanced by 0.58% to $341.5 million in 2026.
  • The last three Cash & Current Investments figures came in at $341.5 million (Q1 2026), $339.5 million (Q4 2025), and $295.3 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 2.13 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 32.30 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 286.70 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 61.46 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 2.77 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 7.25 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 18.44 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 8.75 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 3.01 Bn
10 Pharvaris 267.74 Mn -73.74 Mn - 341.48 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 341.48 Mn
Dec 31, 2025 339.53 Mn
Mar 31, 2025 295.29 Mn
Dec 31, 2024 299.98 Mn
Dec 31, 2023 420.94 Mn
Dec 31, 2022 165.11 Mn
Dec 31, 2021 239.49 Mn
Dec 31, 2020 117.59 Mn
Dec 31, 2019 22.50 Mn